KRAS G12C Inhibitor 25 primarily targets the KRAS G12C mutant by inhibiting the SOS1-assisted GDP/GTP exchange activity, demonstrating an IC50 of 0.48 nM. This compound has potential applications in therapeutic research aimed at KRAS-driven cancers, providing a valuable tool for studying the role of KRAS mutations in tumorigenesis and evaluating potential treatment strategies.
KRAS G12C Inhibitor 25 primarily targets the KRAS G12C mutant by inhibiting the SOS1-assisted GDP/GTP exchange activity, demonstrating an IC50 of 0.48 nM. This compound has potential applications in therapeutic research aimed at KRAS-driven cancers, providing a valuable tool for studying the role of KRAS mutations in tumorigenesis and evaluating potential treatment strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
